Venus Remedies Limited — Important, 22-05-2026: Updates
22-05-2026 · 11:56 am
Venus Remedies secured Saudi FDA approval for Plerixafor, its first global marketing authorization for this oncology therapy. This enables commercialization in Saudi Arabia, a key market, aligning with the company's strategic shift to higher-value specialty injectables in regulated markets.
No comments yet. Be the first to comment!
